More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023 at 18:45 PM EDT
Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the end of March.
